Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05773352 · ClinicalTrials.gov registry record

Perform® Humeral System - Fracture Study (PFX)

A clinical trial of Traumatic Arthritis and Traumatic Arthropathy of Shoulder, sponsored by Stryker Trauma and Extremities.

Active
Registry status
125
Enrollment target
9
Study locations

NCT05773352: Active study of Traumatic Arthritis and Traumatic Arthropathy of Shoulder, sponsored by Stryker Trauma and Extremities.

NCT05773352 is a study of Traumatic Arthritis and Traumatic Arthropathy of Shoulder that is active but no longer recruiting, run by Stryker Trauma and Extremities. The registered enrollment target is 125 participants, below the 396-participant average among 11 other Traumatic Arthritis trials with a reported enrollment target (68% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05773352, a study of Traumatic Arthritis and Traumatic Arthropathy of Shoulder, is active but no longer recruiting, sponsored by Stryker Trauma and Extremities.

ACTIVE NOT RECRUITING
Registry status
125 participants
Enrollment target
9
Study locations

Study Summary

This study is an international, single arm, multicenter, prospective follow-up, non-significant risk, Post-Market Clinical Follow-up (PMCF), which is designed to collect safety and performance data on commercially available Perform® Fracture. Data collected from this study will be used for purposes, including but not limited to, PMS, peer-reviewed publications, education materials, future regulatory submissions, and/or product development.

Primary Outcome

11 items with total score reported out of 100 measuring pain and activity of patient's evaluated shoulder where lower scores indicate more pain and less function

Conditions Studied

Traumatic Arthritis Traumatic Arthropathy of Shoulder Fracture Humerus Revision of Other Devices if Sufficient Bone Stock Remains

Interventions

  • DEVICE Tornier Perform® Humeral System - Fracture

Study Locations (9)

California

  • Eisenhower Health Desert Orthopedic Center - Rancho Mirage
  • California Pacific Orthopaedics - San Francisco

Arizona

  • More Foundation - Phoenix

Arkansas

  • University of Arkansas Medical Sciences - Little Rock

Florida

  • The Center for Bone and Joint Disease - Hudson

Illinois

  • Loyola University Chicago - Maywood

Missouri

  • Washington University - St Louis

Tennessee

  • Tennessee Orthopaedic Alliance - Columbia

Texas

  • University of Texas/UT Health - Houston

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2023-08-31
Est. Completion 2033-09-01
Stryker Trauma and Extremities

30 total trials

What the registry record for NCT05773352 still lists

NCT05773352 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 396-participant average among 11 other Traumatic Arthritis trials with a reported enrollment target (68% lower).

The record links to 4 conditions, with Traumatic Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Tornier Perform® Humeral System - Fracture is the first listed.

NCT05773352 lists 9 locations in 8 states (California, Arizona, Arkansas).

Frequently Asked Questions

What is clinical trial NCT05773352 about?

NCT05773352 is a clinical study titled "Perform® Humeral System - Fracture Study (PFX)". This study is an international, single arm, multicenter, prospective follow-up, non-significant risk, Post-Market Clinical Follow-up (PMCF), which is designed to collect safety and performance data on commercially available Perform® Fracture. Data collected from this study will be used for purposes...

What is the current status of trial NCT05773352?

This trial is currently active not recruiting. The enrollment target is 125 participants. The study started on 2023-08-31. Estimated completion is 2033-09-01.

What conditions does trial NCT05773352 study?

This clinical trial studies the following conditions: Traumatic Arthritis, Traumatic Arthropathy of Shoulder, Fracture Humerus, Revision of Other Devices if Sufficient Bone Stock Remains.

What interventions are being tested in trial NCT05773352?

The interventions under investigation include: Tornier Perform® Humeral System - Fracture (DEVICE).

Who is sponsoring clinical trial NCT05773352?

This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05773352 being conducted?

This trial has 9 study locations across Arizona, Arkansas, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05773352's enrollment target sits among peer trials

125 10th of 11 higher than 2 of 11 other Traumatic Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05773352, the US trial registry maintained by the National Library of Medicine. NCT05773352 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.